NANOG and breast cancer: Specifically, knockdown of ANXA6 suppressed mRNA levels of SOX2, NANOG, OCT4, KLF4, and c-Myc in PR-BC cells (Figures 3F,G), and ANXA6 ablation also restrained PR-BC cells’ spheroid formation abilities (Figures 3H,I).